发明名称 Selective and reversible inhibitors of ubiquitin specific protease 7
摘要 Provided are dihydroquinazolinone derivative compounds of the formula (I’), wherein the variables are as defined in the specification. Examples of the compounds include 3-({ 4-hydroxy-1-[3-(2-methoxyphenyl)propanoyl]piperidin-4-yl} methyl)-3,4-dihydroquinazolin-4-one and 3-{ [1-(2-benzylpropanoyl)-4-hydroxypiperidin-4-yl)methyl} -7-chloro-3,4-dihydroquinazolin-4-one. The compounds are selective and reversible inhibitors of ubiquitin specific protease 7. The compounds may be useful in the treatment of cancer, neurodegenerative diseases, inflammatory disorders and viral infections.
申请公布号 NZ621827(A) 申请公布日期 2016.07.29
申请号 NZ20120621827 申请日期 2012.08.29
申请人 HYBRIGENICS SA 发明人 COLLAND FRÉDÉRIC;GOURDEL MARIE-EDITH
分类号 C07D401/06;A61K31/517;A61P3/00;A61P9/00;A61P19/00;A61P25/00;A61P31/00;A61P35/00;A61P37/00;C07D239/88;C07D239/91;C07D409/14 主分类号 C07D401/06
代理机构 代理人
主权项
地址